Kimberly-Clark/$KMB
1D1W1MYTD1Y5YMAX
Capital at risk
About Kimberly-Clark
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide workplace safety and sanitation solutions. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It is slated to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.
- Ticker
- $KMB
- Sector
- Consumer Essentials
- Primary listing
- NASDAQ
- Employees
- 36,000
- Headquarters
- Dallas, United States
- Website
- www.kimberly-clark.com
Kimberly-Clark Metrics
BasicAdvanced
$35B
17.91
$5.86
0.28
$5.08
4.88%
Price and volume
Market cap
$35B
Beta
0.28
52-week high
$131.53
52-week low
$92.42
Average daily volume
3.5M
Dividend rate
$5.08
Financial strength
Current ratio
0.909
Quick ratio
0.403
Long term debt to equity
346.638
Total debt to equity
348.933
Dividend payout ratio (TTM)
85.88%
Interest coverage (TTM)
12.21%
Profitability
EBITDA (TTM)
3,481
Gross margin (TTM)
37.61%
Net profit margin (TTM)
11.79%
Operating margin (TTM)
17.37%
Effective tax rate (TTM)
29.89%
Revenue per employee (TTM)
$460,000
Management effectiveness
Return on assets (TTM)
10.19%
Return on equity (TTM)
104.91%
Valuation
Price to earnings (TTM)
17.91
Price to revenue (TTM)
2.101
Price to book
19.95
Price to tangible book (TTM)
-226.69
Price to free cash flow (TTM)
19.141
Free cash flow yield (TTM)
5.22%
Free cash flow per share (TTM)
5.484
Dividend yield (TTM)
4.84%
Forward dividend yield
4.88%
Growth
Revenue change (TTM)
0.71%
Earnings per share change (TTM)
-19.37%
3-year revenue growth (CAGR)
-6.59%
10-year revenue growth (CAGR)
-0.99%
3-year earnings per share growth (CAGR)
6.52%
10-year earnings per share growth (CAGR)
0.84%
3-year dividend per share growth (CAGR)
2.77%
10-year dividend per share growth (CAGR)
3.50%
What the Analysts think about Kimberly-Clark
Analyst ratings (Buy, Hold, Sell) for Kimberly-Clark stock.
Analyst projections of the future price of Kimberly-Clark stock.
Bulls say / Bears say
Q2 adjusted EPS rose 10.4% to $2.12, beating consensus by $0.11 and demonstrating robust earnings leverage. (SEC)
Adjusted operating profit increased 6.2% to $757 million in Q2, driven by strong productivity savings, $45 million in tariff refunds, and favorable currency impacts. (SEC)
Year-to-date operating cash flow rose to $1.7 billion versus $1.1 billion a year ago, bolstering liquidity for shareholder returns and debt reduction. (SEC)
Net sales rose just 0.6% to $4.19 billion in Q2, missing analysts’ $4.22 billion forecast and signaling sluggish top-line momentum. (Reuters via Investing.com)
Kimberly-Clark cut full-year organic sales-growth guidance to trail category growth by about 100 basis points—down from a prior in-line forecast—underscoring persistent demand headwinds. (Reuters via Investing.com)
CFO Nelson Urdaneta warned that if oil prices remain near $100 per barrel, the company could face an extra $150 million to $170 million in gross input-cost inflation for H2, potentially eroding margins if not fully mitigated. (Bloomberg)
Data summarised monthly by Lightyear AI. Last updated on 30 Aug 2026.
Kimberly-Clark Financial Performance
Revenues and expenses
Kimberly-Clark Earnings Performance
Company profitability
Upcoming events
Kimberly-Clark News
AllArticlesVideos
Funds containing Kimberly-Clark
AllEURGBPUSD
Fund name | Fund size | $KMB weighting |
|---|---|---|
iShares Dow Jones U.S. Select Dividend€EXX5 | €414M | 1.59% |
iShares S&P 500 Consumer Staples Sector€2B7D | €450M | 1.22% |
iShares S&P 500 Consumer Staples Sector£ICSU | £387M | 1.22% |
iShares MSCI USA Quality Dividend ESG£HDIQ | £579M | 0.57% |
iShares MSCI World Quality Dividend$WQDV | $1.8B | 0.42% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.